Skip to content

Acute Caffeine Intake and Velocity Metrics

Acute Caffeine Ingestion Similarly Enhances Mean and Mean Propulsive Velocity During Resistance Exercise in Trained Men

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07701395
Acronym
CAF+Vel
Enrollment
13
Registered
2026-07-14
Start date
2025-01-01
Completion date
2025-12-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caffeine and Resistance Exercise

Brief summary

The purpose of this study was to determine whether the acute ergogenic effects of caffeine differ according to the velocity metric used to assess strength performance against different relative loads. Thirteen resistance-trained men completed a triple-blind, randomized, placebo-controlled, crossover study. Participants ingested either caffeine (3 mg·kg-1) or a placebo 60 min before performing bench press and back squat exercises at 25%, 50%, 75%, and 90% of one-repetition maximum (1RM). Mean velocity (MV) and mean propulsive velocity (MPV) were simultaneously recorded using a linear position transducer

Interventions

DIETARY_SUPPLEMENTCaffeine

Acute caffeine intake (3 mg·kg-1)

DIETARY_SUPPLEMENTPlacebo

Acute placebo intake (3 mg·kg-1 of maltodextrin)

Sponsors

University of Alcala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

Statistician

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 35 years. * Body Mass Index (BMI) \< 25 kg/m². * Resistance-trained individuals (more than 6 months of structured training). * Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising. * Participants must be able to perform the tests described in the following section.

Exclusion criteria

* History of neuromuscular diseases, heart disease, or conditions that may affect liver or muscle metabolism. * Use of drugs, stimulants, or sports supplements that could interfere with the dietary supplement used in the study. * Sedentary habits (less than 150 minutes/week of moderate exercise). * Having undergone prolonged periods of physical inactivity in the 6 months prior to the study. * Engaging in strenuous exercise within 48 hours prior to the tests.• Failure to replicate the same food intake on both experimental days. * Consumption of caffeine or any other stimulant after 6 pm on the day before the tests, to avoid headaches, discomfort, or lethargy in regular caffeine consumers.

Design outcomes

Primary

MeasureTime frameDescription
Velocity metrics against different relative loads of one-repetition maximumThrough study completion, an average of 3 weeksMeasuring bar mean velocity (during propulsive and braking phases in m/s) and mean propulsive velocity (m/s of the propulsive phase) displacement of the concentric phase during bench press and back squat exercises at 25%, 50%, 75%, and 90%1RM.

Secondary

MeasureTime frameDescription
Adverse effectsThrough study completion, an average of 3 weeksperception of power, endurance, energy and exertion, as well as heart, muscular and gastrointestinal discomfort were measured using a 5-point scale, with scores ranging from 1 (lowest perception or absence of symptoms) to 5 (highest perception or severity).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026